Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1364 of 5804
-
New daily pill could cut migraine days in half
Disease control OngoingThe purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of atogepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a lupus drug shield organs from Long-Term harm?
Disease control CompletedThis is an External control arm study to generate evidence on the comparative effect of anifrolumab plus Standard of Care in TULIP versus Real World Standard of Care on organ damage in adult patients with moderately to severely active Systemic lupus erythematosus (SLE). Patients …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Sound waves aim to quiet opioid cravings
Disease control Recruiting nowThis is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.
Phase: NA • Sponsor: Ali Rezai • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Aged heart cells may hold clues to heart disease progression after attack
Knowledge-focused TerminatedThe investigators of this study have found that after a heart attack, some heart cells rapidly age (become senescent) and release proteins that make the heart disease worse. The investigators of this study would like to check for these aged-cell proteins in participants who have…
Sponsor: South Tees Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New drug duo takes on tough blood cancers
Disease control Recruiting nowThis is a Phase 1 study investigating the safety and efficacy of Danvatirsen as a monotherapy followed by combination with Venetoclax in patients with relapsed/refractory myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML). Funding Source: FDA OOPD
Phase: PHASE1 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a new injection beat insulin for diabetes control?
Disease control CompletedTo compare the efficacy and safety of HR17031 injection and insulin glargine, including the changes of efficacy indicators such as HbA1c, fasting blood glucose, body weight and safety indicators such as adverse events and hypoglycemic events.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for bile duct cancer: experimental combo targets tough tumors
Disease control Recruiting nowBackground: Biliary tract carcinoma (BTC) is cancer of the slender tubes that carry fluids in the liver. People with advanced BTC have few treatment options, and their survival rates are very low. Objective: To test a study drug (CDX-1140) combined 3 other drugs (capecitabine,…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study checks if etrasimod tames ulcerative colitis symptoms in daily life
Disease control Recruiting nowThe purpose of this real world non-interventional study is to learn about the effects of etrasimod as treatment for patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is …
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for HS sufferers: Long-Term drug trial shows promise
Disease control TerminatedThis study is open to people with hidradenitis suppurativa (HS) who have completed another study with spesolimab (study 1368-0098 (NCT05819398) or study 1368-0100). The purpose of this study is to find out how well people tolerate spesolimab and whether it helps people with HS i…
Phase: PHASE2, PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New TB prevention pack tested in thousands of thai households
Prevention CompletedThe project aimed to test a strategy for the early detection and prevention of tuberculosis in household contacts of tuberculosis patients in order to reduce the morbidity, mortality and transmission of this disease in Thailand. This strategy will be evaluated in comparison with …
Phase: NA • Sponsor: Institut de Recherche pour le Developpement • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Free nutrition packs tied to measles shots in nigeria trial
Prevention CompletedProvision of SQ-LNS also holds promise in incentivizing vaccination as well as other health services. The investigators will estimate 1) the effectiveness of a SQ-LNS mass supplementation program added to routine immunization program compared to routine immunization program alon…
Phase: NA • Sponsor: Alliance for International Medical Action • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Gene test + MRI may catch deadly prostate cancer earlier
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate a screening method to detect clinically relevant prostate cancer. This clinical trial is using genetic data to determine a man's risk of cancer, together with multiparametric magnetic resonance imaging (mpMRI) to identify men with hi…
Phase: NA • Sponsor: Adam S. Kibel, MD • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo aims to tame stem cell transplant complications
Disease control Recruiting nowAllogeneic hematopoietic cell transplantation (HCT) is one of the only curative intent therapies available for hematologic malignancies. HLA-matched sibling donors have historically offered the best clinical results but are unavailable for the majority of patients, while most pat…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Sleep your way to better mental health: new study targets postpartum depression during pregnancy
Prevention Recruiting nowImproving maternal mental health is a worldwide health priority. Nevertheless, several scientific sources highlighted lack of empirical data which could drive clinical practice. The present project addresses psychobiological mechanisms leading to peripartum mental disorders. It f…
Phase: NA • Sponsor: University of Rome G. Marconi • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New Two-Step valve procedure aims to cut lung collapse risk in emphysema patients
Disease control Recruiting nowChronic obstructive pulmonary disease (COPD) affects 3.5 million people and is the third leading cause of death worldwide. Emphysema involves air retention in the lungs and is ultimately responsible for a major deterioration in the quality of life. Available drug treatments have …
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Virus therapy takes on tough tumors
Disease control Recruiting nowSubjects were Chinese patients with histologically or cytologically confirmed advanced malignant solid tumors (mainly focused on MSS type colon and rectal cancer) who had failed standard systemic therapy and were inoperable. The first stage was the dose escalation stage, which w…
Phase: EARLY_PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New combo drug CagriSema shows promise for diabetes control
Disease control CompletedThis study will look at how CagriSema, semaglutide and cagrilintide regulate insulin effects in the body of people with type 2 diabetes (T2D). CagriSema is a new investigational medicine that combines two medicines called cagrilintide and semaglutide. Doctors may not yet prescrib…
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New injection aims to help obese heart failure patients lose weight and feel better
Disease control OngoingThis was a multicenter, randomized, double-blind, placebo-parallel-controlled Phase II clinical study to evaluate the efficacy and safety of HRS9531 Injection compared to placebo in obese subjects with heart failure with preserved ejection fraction. A total of 200 obese subjects…
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Virtual reality offers new hope for chronic pain sufferers
Symptom relief CompletedThis clinical trial evaluates the effectiveness of the REDOCVR program, an interdisciplinary, psychoeducational intervention designed to support deprescribing of chronic pain medications in primary care. REDOCVR integrates group-based education, physical activation, and emotional…
Phase: NA • Sponsor: Badalona Serveis Assistencials • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Silver spray boosts wound healing in diabetic foot patients?
Disease control ENROLLING_BY_INVITATIONThis was a prospective, parallel-group, randomized controlled trial conducted at the Vascular Surgery Department of Kafrelsheikh University Hospital, Egypt. The study was approved by the Institutional Review Board and conducted in accordance with the Declaration of Helsinki. Writ…
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 26, 2026 15:24 UTC